首页> 外文期刊>Pediatric Cardiology >Neonatal Patent Ductus Arteriosus Recanalization and Stenting in Critical Ebstein’s Anomaly
【24h】

Neonatal Patent Ductus Arteriosus Recanalization and Stenting in Critical Ebstein’s Anomaly

机译:严重埃伯斯坦异常中的新生儿动脉导管未闭再通和支架置入术

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A critically ill 3-day-old neonate with severe tricuspid valve Ebstein’s anomaly, functional pulmonary atresia, and closed ductus arteriosus, unresponsive to prostaglandin infusion, underwent percutaneous ductal recanalization and stenting as an alternative to a surgical shunt. After local prostaglandin infusion through an end-hole catheter, the ductus was passed using a hydrophilic, high-support coronary guidewire. It was then stabilized by coronary stent implantation, after which the arterial oxygen saturation showed a sudden rise. In conclusion, ductus arteriosus recanalization and stenting can be successfully achieved within a few days after spontaneous closure as a cost-effective alternative to a surgical shunt for critical neonatal, duct-dependent Ebstein’s anomaly.
机译:危重病的3天大婴儿,患有严重的三尖瓣Ebstein异常,功能性肺动脉闭锁和动脉导管闭合,对前列腺素输注无反应,进行了经皮导管再通和支架置入术,以替代手术分流术。通过端孔导管局部注入前列腺素后,使用亲水性高支撑冠状动脉导丝通过导管。然后通过冠状动脉支架植入使其稳定,此后动脉血氧饱和度突然升高。总而言之,自发闭合后几天内,动脉导管再通和支架置入术可以成功完成,这是对严重的新生儿导管依赖型Ebstein异常进行手术分流的经济有效替代方案。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号